首页> 外文期刊>Current atherosclerosis reports. >Ultrasound imaging of carotid intima-media thickness: an office-based tool to assist physicians in cardiovascular risk assessment.
【24h】

Ultrasound imaging of carotid intima-media thickness: an office-based tool to assist physicians in cardiovascular risk assessment.

机译:颈动脉内中膜厚度的超声成像:一种基于办公室的工具,可帮助医生进行心血管风险评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Traditional coronary heart disease risk prediction schemes such as the Framingham Risk Score, although useful, do not adequately identify all individuals who experience an adverse coronary heart disease event. Therefore, additional tools, including biomarkers, genetic markers, and imaging markers, are being evaluated for their value in improving cardiovascular risk assessment. Of the two accepted imaging markers of atherosclerosis, namely coronary artery calcium score (CACS) measured by CT scan and carotid intima-media thickness (CIMT) measured by ultrasound, CIMT has the potential to be widely adopted as a clinical tool for physician offices. Ultrasound-based CIMT measurement is safe but has several challenges, including reproducibility and operator-dependency. We review and present data with respect to the added value of CIMT and information about plaque presence or absence in improving coronary heart disease risk prediction and further provide information related to adequate scanning protocols. New developments in the area of automated CIMT measurement, three-dimensional, ultrasound-based plaque volume estimation are promising and have the potential to create a quantum leap in our ability to measure, characterize, and monitor carotid atherosclerosis and in turn prediction of cardiovascular disease risk.
机译:传统的冠心病风险预测方案(例如Framingham风险评分)虽然有用,但并不能充分识别经历不良冠心病事件的所有个体。因此,正在评估其他工具,包括生物标志物,遗传标志物和成像标志物,以提高心血管风险评估的价值。在通过CT扫描测量的冠状动脉钙评分(CACS)和通过超声测量的颈动脉内中膜厚度(CIMT)的两个公认的动脉粥样硬化成像标志物中,CIMT有潜力被广泛用作医师办公室的临床工具。基于超声的CIMT测量是安全的,但存在一些挑战,包括重现性和操作者依赖性。我们审查并提出有关CIMT附加值的数据以及有关斑块存在与否的信息,以改善冠心病风险预测,并进一步提供与足够的扫描方案有关的信息。自动化CIMT测量,基于超声的三维三维斑块体积估计领域的新发展令人鼓舞,并有可能在我们测量,表征和监测颈动脉粥样硬化以及进而预测心血管疾病的能力方面实现巨大飞跃风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号